中药益发联合糖皮质激素对重型斑秃患者糖皮质激素受体mRNA表达的影响
|
摘要
目的:
观察中药益发口服液联合糖皮质激素(GC)治疗重型斑秃的临床疗效及药理机制。通过检测重型斑秃患者血皮质醇水平及外周血单个核细胞(PBMCs)中糖皮质激素受体(GR)mRNA的表达水平,探讨重型斑秃的发病机理,分析GR表达水平与病情程度及临床疗效的关系,进而深入探讨中药联合GC与糖皮质激素受体之间的关系。
方法:
参照《中药新药临床研究指导原则》第三辑内容,选择经临床确诊为重型斑秃并且中医辨证分型属肝肾不足证的患者32例,并设正常健康人对照组20例。将32例重型斑秃病人随机分为中西结合组(17例)和西药组(15例),中医结合组予益发口服液,每次20ml,每天3次;强的松0.25mg/kg,早8时一次顿服,每天1次,法莫替丁片20mg,口服,每天2次。西药组予强的松及法莫替丁片口服,用法用量同中西结合组。两组均治疗6个月后评定疗效,疗效性指标包括:治疗期间头发脱落的根数;治疗期间新发长出的面积;新生头发的密度、粗细、色泽;病人的整体状况。疗效判定标准参照《中药新药临床研究指导原则》第三辑有关内容。治疗前后均观察两组患者血、尿、便常规、心、肝、肾功能(EKG,ALT,AST,BUN,Cr)及不良反应情况。应用化学发光法检测正常对照组以及重型斑秃患者治疗前血清皮质醇含量并比较。应用逆转录-实时荧光定量聚合酶链反应(RT-qRealTime-PCR)检测正常对照组以及重型斑秃患者治疗前、后的GRmRNA表达水平并比较。采用SPSS13.0统计软件包建立数据库并进行统计分析。
结果:
(一)血清皮质醇方面:重型斑秃患者治疗前血清中皮质醇浓度与正常对照组相比无显著性差异(P＞0.05);中西结合组与西药组两组的血皮质醇浓度比较,差异也是无统计学意义(P＞0.05)。
(二) GRmRNA表达水平方面:
1.正常对照组与重型斑秃病例组比较:正常对照组与重型斑秃病例组PBMCs均有GRmRNA表达,重型斑秃患者治疗前、后GRmRNA表达水平均低于正常对照组,差异有统计学意义(P＜0.05);并且治疗后GRmRNA表达水平比治疗前更低,差异有统计学意义(P＜0.01)。
2.中西结合组和西药组比较:(1)组内比较:两组治疗后GRmRNA表达水平均较治疗前明显降低,经配对样本比较,差异均有显著性意义,中医结合组(P＜0.05),西药组(P＜0.01)。但西药组比中西医组下降幅度更大。(2)组间比较:治疗前,中西结合组与西药组外周血GRmRNA表达水平无显著性差异(P＞0.05)。治疗后,中西结合组GRmRNA表达水平要明显高于西药组,差异有统计学意义(P＜0.05)。
(三)疗效比较:采用符合方案集分析(PP)对依从性好且完成试验的受试者进行分析;采用ITT意图治疗分析(ITT)对全部的受试者进行统计分析。方案集分析:中西结合组治愈率58.82%,总有效率为94.1%;西药组治愈率为40%,总有效率为80%,两组间差异有统计学意义(P＜0.05)。两组的意图治疗数据集疗效比较结果与方案集分析结果相同。两组的不良反应比较,差异无显著性意义(P＞0.01)。
(四)按脱发面积分为普秃、全秃、斑片组,结果斑片组GRmRNA表达水平较高。普秃、全秃组GRmRNA表达水平较低。
(五)按疗效分成痊愈、显效、有效、无效四组,结果四组治疗前的GRmRNA表达水平组间比较无统计学差异(P＞0.05)。但四组治疗后的GRmRNA表达水平组间比较差异有统计学意义(P＜0.05)。组内比较:痊愈、显效、有效组治疗前后GRmRNA的差值比较差异均有统计学意义(P＜0.05);无效组治疗前后GRmRNA差值比较差异无统计学意义(P＞0.05)。
结论:
通过本次研究得到以下结论:
1.国内外首次报道重型斑秃患者治疗前血皮质醇含量与正常对照相比无显著性差异,但外周血单一核细胞上的GR mRNA表达水平明显降低。表明重型斑秃患者存在GC-GR紊乱,GRmRNA表达水平降低可能参与了重型斑秃的发病机制。
2.国内外首次报道肝肾不足证型的重型斑秃患者外周血单一核细胞上的GRmRNA表达水平显著低于正常对照组,这可能是重型斑秃肝肾不足证型在受体及基因水平上的病理变化。GRmRNA表达水平能否作为肝肾不足证型的现代病理学量化依据,还有待进一步深入的研究。
3.国内外首次报道中西结合组治疗后GRmRNA表达水平要明显高于西药组,中西结合组治疗重型斑秃疗效要优于单纯西药组。表明益发口服液与GC合用,可提高患者血GRmRNA表达,或能减轻激素对自身受体的下调作用,从而增强GC敏感性,保证GC与GR的结合水平。从中也提示益发口服液联合GC治疗斑秃的作用与其对GR的调节作用有一定关联,这可能是益发口服液治疗斑秃的作用机制之一。
4.国内外首次报道病情较轻的,GRmRNA表达水平较高。病情较重,GRmRNA表达水平较低。因此检测GRmRNA表达水平对判断重型斑秃的预后有一定作用。
5.国内外首次报道疗效好的重型斑秃患者其PBMCs中GR mRNA表达水平相对高,疗效差者GR mRNA表达水平相对低。提示如果对反应不佳的患者盲目加大GC的用量只会增加不良反应,弊大于利。推测重型斑秃患者治疗前PBMCs中GRmRNA表达水平的检测可能有助于预测患者对GC的效果,也许能作为指导治疗与预后的参考指标之一。
Objective
To analyze the pharmacological mechanism of YIFA oral liquid combined whth glucocorticoid(GC) through the observation of its clinical treatment effect on severe alopecia areata patients.To investigate the pathogenesis of severe alopecia areata by detecting the level of glucocorticoid receptors(GR)mRNA in peripheral blood mononuclear cells(PBMCs) from patients with severe alopecia areata.Analyze both the relationship between the expression level of GR and pathogenetic condition,and between the the expression level of GR and clinical effect.Further more to explore the relationship between GR and Chinese medicine combined with GC.
Methods
According to the third album《guide line of Chinese herbal medicine clinical research》,32 cases clinical diagnosed as severe alopecia areata and deficiency of liver and kidney as their TCM syndrome were selected.And 20 cases as normal control group.32 cases of severe alopecia areata patients were randomly divided into integrated Chinese and western medicine group(17 cases) and western medicine group(15 cases).Integrated Chinese and western medicine group was given YIFA oral liquid,20ml each time and three times a day;prednisone 0.25mg/kg,every 8 a.m.;famotidine 20mg each time,twice a day.Western medicine group was given prednisone and famotidine only,usage and dosage with integrated Chinese and western medicine group.Evaluting the treatment effect of two groups after six months treatment.The therapeutic indexes including:the root of hair loss during treatment,the new hair area during treatment,the color,density,thickness of new hair and the whole situation of the patients.The criteria for treatment effect also reffered to the third album《guide line of Chinese herbal medicine clinical research》. The patients of two groups were observed blood routine,urine routine,soil routine,cardiac function(EKG),liver function(ALT,AST),renal function(BUN, Cr) and adverse reactions before and after treatment.Before treament,serum cortisol levels was measured by Chemiluminescence from 32 cases of severe alopeeia areata patients and 20 normal controls.GR was measured by reverse transcription-real time fluorescence quantitative polymerase chain reaction (RT-FQRealTime-PCR) from severe alopecia areata patients(before and after treatment) and normal controls.The data were inputted into a computer and were analyzed by statistical package for the social science(SPSS) 13.0.
Results
(A).Comparison of serum cortisol level:
Serum cortisol level from severe alopecia areata patients had no significant difference compared to the normal controls(P＞0.05);Serum cortisol level between integrated Chinese and western medicine group and western medicine group alos had no significant difference(P＞0.05).
(B).Comparison of the GRmRNA expression level
1.The normal control group compared with severe alopecia areata patients group:
GRmRNA was detected in PBMCs from all severe alopecia areata patients and the normal controls.The expression of GRmRNA before and after treatment of severe alopecia areata patients was significantly lower than that of the normal controls(P＜0.05);And the expression of GRmRNA after treatment of alopecia areata patients was significantly lower than that before treatment(P＜0.01).
2.Integrated Chinese and western medicine group compared with western medicine group1:
(1) Comparison within the groups
GRmRNA expression level after treatment of two groups was significantly lower than that before treatment by two pairs sample comparison.And western medicine group dropped greater than integrated Chinese and western medicine group.Integrated Chinese and western medicine group(P＜0.05),western medicine group(P＜0.01).
(2) Comparison between the groups
Before treatment,GRmRNA expression level of integrated Chinese and western medicine group had no significant difference compared to western medicine group(P＞0.05).After treatment,GRmRNA expression of integrated Chinese and western medicine group was significantly higher than that of western medicine group(P＜0.05).
(C).Comparison of treatment effect
Analyzed the testers with PP analysis who had good compliance and complete treatmeat test.Analyzed all the testers with ITT analysis.PP analysis:the cure rate of integrated Chinese and western medicine group was 58.82%,while the total effective rate was 94.1%.Tthe curative rate of western medicine group was 40%,while the total effective rate was 80%.The cure rate and the total effective rate of integrated Chinese and western medicine group was significantly higher than that of western medicine group(P＜0.05).The results of ITT analysis was the same to the results of PP analysis.The adverse reactions between integrated Chinese and western medicine group and western medicine group had no significant difference(P＞0.01).
(D).The patients were divided into alopecia universalis group,alopecia totalis group and patiching group according to the bald area.As the result, the GRmRNA expression lever of patiching group was significantly higher than that of alopecia universalis group and alopecia capitis totalis group.
(E).According to the treatment effect,the patients were divided into recovery group,excellence group,effective group and ineffective group.GRmRNA expression level before treatment of four groups had no statistically difference(P＞0.05).But after treatment,GRmRNA expression level of four groups had significant difference(P＜0.05).Comparison within the groups: Before and after treatment,the differential value of GRmRNA expression level in recovery group,excellence group and effective group had significant difference(P＜0.05);While the differential value of GRmRNA expression level in ineffective group had no significant difference(P＞0.05).
Conclusion
We can draw a conclusion as the following:
1.We firstly reported that serum cortisol level from severe alopecia areata patients had no significant difference compared to the normal controls. However,the expression of GRmRNA of severe alopecia areata patients was significantly lower than that of the normal controls.It suggested that the disorder of GC-GR exist in alopecia areata patients.And the decrease of GRmRNA in peripheral blood mononuclear cells may be invoved in the pathogenesis of severe alopecia areata
2.We firstly reported that the expression of GRmRNA in peripheral blood mononuclear cells of severe alopecia areata patients and deficiency of liver and kidney as their TCM syndrome was significantly lower than that of the normal controls(P＜0.05).This maybe the pathological change on receptor and gene level in severe alopecia areata patients and deficiency of liver and kidney as their TCM syndrome.It depends on further research that whether GRmRNA expression level can be the mordern pathology quantitative basis or not.
3.We firstly reported that GRmRNA expression of integrated Chinese and western medicine group after treatment was significantly higher than that of western medicine group.The treatment effect of integrated Chinese and western medicine group was better that that of western medicine group.It indicated that YIFA oral liquid combined with glucocorticoid can raise GRmRNA expression of severe alopecia areata patients,or decrease the down-regulation of glucocorticoid towards its receptor,which can increase the sensibility of glucocorticoid and guarantee the binding level between GC and GR.It pointed out that the treatment effect of YIFA oral liquid combined with glucocorticoid was related to its regulation towards GR.This maybe one of the action mechanism of YIFA oral liquid to alopecia areata.
4.We firstly reported that the ligher pathogenetic condition was,the higher GRmRNA level expressed.On the contrary,the heavier pathogenetic condition was,the lower GRmRNA level expressed.For this reason,examining GRmRNA expression level is useful in judging the prognosis of severe alopecia areata.
5.We firstly reported that the better the treatment effect was the higher GRmRNA expressed in PBMCs of severe alopecia areata.On the contrary,the worse the treatment effect was the lower GRmRNA expressed.It indicated it would increases adverse reactions if we blindly increase the dosage of GC to the patients who had bad response to GC.Disadvantage would exceed disadvantage. It is supposed that examining GRmRNA expression level of severe alopecia areata before treatment maybe contribute to the effect prediction which the patients towards GC.Moreover it maybe one of the reference index to direct treatment and prognosis.
观察中药益发口服液联合糖皮质激素(GC)治疗重型斑秃的临床疗效及药理机制。通过检测重型斑秃患者血皮质醇水平及外周血单个核细胞(PBMCs)中糖皮质激素受体(GR)mRNA的表达水平,探讨重型斑秃的发病机理,分析GR表达水平与病情程度及临床疗效的关系,进而深入探讨中药联合GC与糖皮质激素受体之间的关系。
方法:
参照《中药新药临床研究指导原则》第三辑内容,选择经临床确诊为重型斑秃并且中医辨证分型属肝肾不足证的患者32例,并设正常健康人对照组20例。将32例重型斑秃病人随机分为中西结合组(17例)和西药组(15例),中医结合组予益发口服液,每次20ml,每天3次;强的松0.25mg/kg,早8时一次顿服,每天1次,法莫替丁片20mg,口服,每天2次。西药组予强的松及法莫替丁片口服,用法用量同中西结合组。两组均治疗6个月后评定疗效,疗效性指标包括:治疗期间头发脱落的根数;治疗期间新发长出的面积;新生头发的密度、粗细、色泽;病人的整体状况。疗效判定标准参照《中药新药临床研究指导原则》第三辑有关内容。治疗前后均观察两组患者血、尿、便常规、心、肝、肾功能(EKG,ALT,AST,BUN,Cr)及不良反应情况。应用化学发光法检测正常对照组以及重型斑秃患者治疗前血清皮质醇含量并比较。应用逆转录-实时荧光定量聚合酶链反应(RT-qRealTime-PCR)检测正常对照组以及重型斑秃患者治疗前、后的GRmRNA表达水平并比较。采用SPSS13.0统计软件包建立数据库并进行统计分析。
结果:
(一)血清皮质醇方面:重型斑秃患者治疗前血清中皮质醇浓度与正常对照组相比无显著性差异(P＞0.05);中西结合组与西药组两组的血皮质醇浓度比较,差异也是无统计学意义(P＞0.05)。
(二) GRmRNA表达水平方面:
1.正常对照组与重型斑秃病例组比较:正常对照组与重型斑秃病例组PBMCs均有GRmRNA表达,重型斑秃患者治疗前、后GRmRNA表达水平均低于正常对照组,差异有统计学意义(P＜0.05);并且治疗后GRmRNA表达水平比治疗前更低,差异有统计学意义(P＜0.01)。
2.中西结合组和西药组比较:(1)组内比较:两组治疗后GRmRNA表达水平均较治疗前明显降低,经配对样本比较,差异均有显著性意义,中医结合组(P＜0.05),西药组(P＜0.01)。但西药组比中西医组下降幅度更大。(2)组间比较:治疗前,中西结合组与西药组外周血GRmRNA表达水平无显著性差异(P＞0.05)。治疗后,中西结合组GRmRNA表达水平要明显高于西药组,差异有统计学意义(P＜0.05)。
(三)疗效比较:采用符合方案集分析(PP)对依从性好且完成试验的受试者进行分析;采用ITT意图治疗分析(ITT)对全部的受试者进行统计分析。方案集分析:中西结合组治愈率58.82%,总有效率为94.1%;西药组治愈率为40%,总有效率为80%,两组间差异有统计学意义(P＜0.05)。两组的意图治疗数据集疗效比较结果与方案集分析结果相同。两组的不良反应比较,差异无显著性意义(P＞0.01)。
(四)按脱发面积分为普秃、全秃、斑片组,结果斑片组GRmRNA表达水平较高。普秃、全秃组GRmRNA表达水平较低。
(五)按疗效分成痊愈、显效、有效、无效四组,结果四组治疗前的GRmRNA表达水平组间比较无统计学差异(P＞0.05)。但四组治疗后的GRmRNA表达水平组间比较差异有统计学意义(P＜0.05)。组内比较:痊愈、显效、有效组治疗前后GRmRNA的差值比较差异均有统计学意义(P＜0.05);无效组治疗前后GRmRNA差值比较差异无统计学意义(P＞0.05)。
结论:
通过本次研究得到以下结论:
1.国内外首次报道重型斑秃患者治疗前血皮质醇含量与正常对照相比无显著性差异,但外周血单一核细胞上的GR mRNA表达水平明显降低。表明重型斑秃患者存在GC-GR紊乱,GRmRNA表达水平降低可能参与了重型斑秃的发病机制。
2.国内外首次报道肝肾不足证型的重型斑秃患者外周血单一核细胞上的GRmRNA表达水平显著低于正常对照组,这可能是重型斑秃肝肾不足证型在受体及基因水平上的病理变化。GRmRNA表达水平能否作为肝肾不足证型的现代病理学量化依据,还有待进一步深入的研究。
3.国内外首次报道中西结合组治疗后GRmRNA表达水平要明显高于西药组,中西结合组治疗重型斑秃疗效要优于单纯西药组。表明益发口服液与GC合用,可提高患者血GRmRNA表达,或能减轻激素对自身受体的下调作用,从而增强GC敏感性,保证GC与GR的结合水平。从中也提示益发口服液联合GC治疗斑秃的作用与其对GR的调节作用有一定关联,这可能是益发口服液治疗斑秃的作用机制之一。
4.国内外首次报道病情较轻的,GRmRNA表达水平较高。病情较重,GRmRNA表达水平较低。因此检测GRmRNA表达水平对判断重型斑秃的预后有一定作用。
5.国内外首次报道疗效好的重型斑秃患者其PBMCs中GR mRNA表达水平相对高,疗效差者GR mRNA表达水平相对低。提示如果对反应不佳的患者盲目加大GC的用量只会增加不良反应,弊大于利。推测重型斑秃患者治疗前PBMCs中GRmRNA表达水平的检测可能有助于预测患者对GC的效果,也许能作为指导治疗与预后的参考指标之一。
Objective
To analyze the pharmacological mechanism of YIFA oral liquid combined whth glucocorticoid(GC) through the observation of its clinical treatment effect on severe alopecia areata patients.To investigate the pathogenesis of severe alopecia areata by detecting the level of glucocorticoid receptors(GR)mRNA in peripheral blood mononuclear cells(PBMCs) from patients with severe alopecia areata.Analyze both the relationship between the expression level of GR and pathogenetic condition,and between the the expression level of GR and clinical effect.Further more to explore the relationship between GR and Chinese medicine combined with GC.
Methods
According to the third album《guide line of Chinese herbal medicine clinical research》,32 cases clinical diagnosed as severe alopecia areata and deficiency of liver and kidney as their TCM syndrome were selected.And 20 cases as normal control group.32 cases of severe alopecia areata patients were randomly divided into integrated Chinese and western medicine group(17 cases) and western medicine group(15 cases).Integrated Chinese and western medicine group was given YIFA oral liquid,20ml each time and three times a day;prednisone 0.25mg/kg,every 8 a.m.;famotidine 20mg each time,twice a day.Western medicine group was given prednisone and famotidine only,usage and dosage with integrated Chinese and western medicine group.Evaluting the treatment effect of two groups after six months treatment.The therapeutic indexes including:the root of hair loss during treatment,the new hair area during treatment,the color,density,thickness of new hair and the whole situation of the patients.The criteria for treatment effect also reffered to the third album《guide line of Chinese herbal medicine clinical research》. The patients of two groups were observed blood routine,urine routine,soil routine,cardiac function(EKG),liver function(ALT,AST),renal function(BUN, Cr) and adverse reactions before and after treatment.Before treament,serum cortisol levels was measured by Chemiluminescence from 32 cases of severe alopeeia areata patients and 20 normal controls.GR was measured by reverse transcription-real time fluorescence quantitative polymerase chain reaction (RT-FQRealTime-PCR) from severe alopecia areata patients(before and after treatment) and normal controls.The data were inputted into a computer and were analyzed by statistical package for the social science(SPSS) 13.0.
Results
(A).Comparison of serum cortisol level:
Serum cortisol level from severe alopecia areata patients had no significant difference compared to the normal controls(P＞0.05);Serum cortisol level between integrated Chinese and western medicine group and western medicine group alos had no significant difference(P＞0.05).
(B).Comparison of the GRmRNA expression level
1.The normal control group compared with severe alopecia areata patients group:
GRmRNA was detected in PBMCs from all severe alopecia areata patients and the normal controls.The expression of GRmRNA before and after treatment of severe alopecia areata patients was significantly lower than that of the normal controls(P＜0.05);And the expression of GRmRNA after treatment of alopecia areata patients was significantly lower than that before treatment(P＜0.01).
2.Integrated Chinese and western medicine group compared with western medicine group1:
(1) Comparison within the groups
GRmRNA expression level after treatment of two groups was significantly lower than that before treatment by two pairs sample comparison.And western medicine group dropped greater than integrated Chinese and western medicine group.Integrated Chinese and western medicine group(P＜0.05),western medicine group(P＜0.01).
(2) Comparison between the groups
Before treatment,GRmRNA expression level of integrated Chinese and western medicine group had no significant difference compared to western medicine group(P＞0.05).After treatment,GRmRNA expression of integrated Chinese and western medicine group was significantly higher than that of western medicine group(P＜0.05).
(C).Comparison of treatment effect
Analyzed the testers with PP analysis who had good compliance and complete treatmeat test.Analyzed all the testers with ITT analysis.PP analysis:the cure rate of integrated Chinese and western medicine group was 58.82%,while the total effective rate was 94.1%.Tthe curative rate of western medicine group was 40%,while the total effective rate was 80%.The cure rate and the total effective rate of integrated Chinese and western medicine group was significantly higher than that of western medicine group(P＜0.05).The results of ITT analysis was the same to the results of PP analysis.The adverse reactions between integrated Chinese and western medicine group and western medicine group had no significant difference(P＞0.01).
(D).The patients were divided into alopecia universalis group,alopecia totalis group and patiching group according to the bald area.As the result, the GRmRNA expression lever of patiching group was significantly higher than that of alopecia universalis group and alopecia capitis totalis group.
(E).According to the treatment effect,the patients were divided into recovery group,excellence group,effective group and ineffective group.GRmRNA expression level before treatment of four groups had no statistically difference(P＞0.05).But after treatment,GRmRNA expression level of four groups had significant difference(P＜0.05).Comparison within the groups: Before and after treatment,the differential value of GRmRNA expression level in recovery group,excellence group and effective group had significant difference(P＜0.05);While the differential value of GRmRNA expression level in ineffective group had no significant difference(P＞0.05).
Conclusion
We can draw a conclusion as the following:
1.We firstly reported that serum cortisol level from severe alopecia areata patients had no significant difference compared to the normal controls. However,the expression of GRmRNA of severe alopecia areata patients was significantly lower than that of the normal controls.It suggested that the disorder of GC-GR exist in alopecia areata patients.And the decrease of GRmRNA in peripheral blood mononuclear cells may be invoved in the pathogenesis of severe alopecia areata
2.We firstly reported that the expression of GRmRNA in peripheral blood mononuclear cells of severe alopecia areata patients and deficiency of liver and kidney as their TCM syndrome was significantly lower than that of the normal controls(P＜0.05).This maybe the pathological change on receptor and gene level in severe alopecia areata patients and deficiency of liver and kidney as their TCM syndrome.It depends on further research that whether GRmRNA expression level can be the mordern pathology quantitative basis or not.
3.We firstly reported that GRmRNA expression of integrated Chinese and western medicine group after treatment was significantly higher than that of western medicine group.The treatment effect of integrated Chinese and western medicine group was better that that of western medicine group.It indicated that YIFA oral liquid combined with glucocorticoid can raise GRmRNA expression of severe alopecia areata patients,or decrease the down-regulation of glucocorticoid towards its receptor,which can increase the sensibility of glucocorticoid and guarantee the binding level between GC and GR.It pointed out that the treatment effect of YIFA oral liquid combined with glucocorticoid was related to its regulation towards GR.This maybe one of the action mechanism of YIFA oral liquid to alopecia areata.
4.We firstly reported that the ligher pathogenetic condition was,the higher GRmRNA level expressed.On the contrary,the heavier pathogenetic condition was,the lower GRmRNA level expressed.For this reason,examining GRmRNA expression level is useful in judging the prognosis of severe alopecia areata.
5.We firstly reported that the better the treatment effect was the higher GRmRNA expressed in PBMCs of severe alopecia areata.On the contrary,the worse the treatment effect was the lower GRmRNA expressed.It indicated it would increases adverse reactions if we blindly increase the dosage of GC to the patients who had bad response to GC.Disadvantage would exceed disadvantage. It is supposed that examining GRmRNA expression level of severe alopecia areata before treatment maybe contribute to the effect prediction which the patients towards GC.Moreover it maybe one of the reference index to direct treatment and prognosis.
引文
[1]刘惠芸.论内治斑秃六法[J].光明中医,2004,19(4):31-32
[2]赵艳霞,陈学荣.陈学荣教授中医治疗脱发的临床经验[J]中国中西医结合皮肤性病学杂志,2006,5(2):103
[3]马纯清.补阳还五汤加味应用举隅[J].长春中医药大学学报.2006,22(4):24-25
[4]王丽华.益肾养血汤治疗斑秃40例[J].河北中医,2006,28(3):182-182
[5]王卫.六味地黄汤治疗斑秃的体会[J].中华现代中西医杂志,2005,3(7):637-637
[6]陈忠春.生发汤治疗斑秃260例疗效观察[J].中国中西医结合皮肤性病学杂志,2004,3(3):165-166.
[7]程晓春,龚一云,岳代荣.补阳还五汤加味治疗斑秃80例[J].四川中医,2004,22(2):72-73
[8]张凌.自拟补肾活血驱风汤治疗斑秃32例[J].福建中医药,2006,37(1):34.
[9]卢纬花.逍遥散加减治疗斑秃48例[J].实用中医杂志,2007,23(7):436
[10]赵义恩 赵泽恩.桑楮生发汤治疗斑秃36例[J].四川中医,2004,22(1):82-8
[11]袁翠英.中医药治疗斑秃102例[J].中华皮肤科杂志,2004,37(2):113-113
[12]潘权.自拟苦参汤治疗斑秃21例疗效观察[J].哈尔滨医药,2003,23(5):41-42
[13]张贵菊,龙雪.首乌神应丹治疗斑秃76例观察[J].实用中医药杂志,2006,22(8):470.
[14]朱培成.松针滋肾生发汤治疗斑秃的疗效[J].广东医学,2007年,28(12):2030-2031
[15]李云华,马俊彦.疏肝活血法治疗斑秃的体会[J].云南中医学院学报,2004,27(4):44-45
[16]杨红.柴胡疏肝散加减治疗斑秃100例[J].中国中西医结合皮肤性病学杂志,2005,4(1):43.
[17]胡爱玲.内外同治斑秃18例疗效观察[J].湖南中医杂志,2008,24(2):42-43
[18]刘爱民 吴晓霞 禤国维.血瘀与活血化瘀在斑秃发病及治疗中的作用[J].浙江中医杂志,2004,39(1):10-11
[19]马艳春.从痰热论治斑秃38例[J].黑龙江中医药杂志,2007,24(6):44
[20]李秀潘.斑秃证治与阴阳转折疗法[J].辽宁中医杂志,2006,33(10):1349.
[21]袁新顺.中医综合疗法治斑秃34例[J].中国民间疗法,2004,12(7):38-39
[22]谢雄飞.梅花针配合中药酊外搽治疗斑秃100例[J].中国中医药杂志,2005,3(11):1026-1026
[23]温瑞书,刘忙柱.化瘀生发汤配合皮肤针治疗斑秃56例[J].四川中医,2003, 21(7):85-85
[24]刘秀玲.穴位注射合辨证分型治疗斑秃130例[J].福建中医学院学报,2003,13(3):11-11
[25]吴晓永.针药并用治疗斑秃96例临床观察[J].中华综合医学杂志(河北),2003,5(5):62-63
[26]戴蜀平.针药并用治疗斑秃临床观察.辽宁中医杂志,2003,30(9):749-749)
[27]王敏华,于雪梅,邓家侵,等.中医综合疗法治疗斑秃的疗效观察[J].2007,25.(9):100
[28]张恒耀,李鸣九,黄青林,等.综合疗法治疗斑秃68例疗效观察[J].新巾医,2006,38(4):66
[29]于洪芝.四联疗法治疗斑秃疗效观察[J].岭南皮肤性病科杂志,2008,15(4):216-217
[30]赖晓梅,曹艳霞,刘健.电针加药物注射治疗斑秃62例疗效观察[J].四川中医,2004,22(2):77--78.
[31]陈金兰.针刺配合中药治疗斑秃80例[J].辽宁中医杂志,2007,34(12):1791
[32]陈训军,丹红酊治疗斑秃38例[J].医药导报,2003,22(1):50
[33]赵昌兰.皮肤病外治验案举隅[J].中华现代皮肤科学杂志,2005,2(1):70-70
[34]梁绿茵 蔡敬宙 何颖妉.梅花针加万丝林喷雾剂治疗瘀血阻络型斑秃临床研究[J].辽宁中医杂志,2004,31(7):598-599
[35]何良新.斑蝥酊治疗斑秃64例[J].中国现代中西医结合,2004,1(4):330-33
[36]曹晓丽,韦宗杰.梅花针加自拟中药酊剂治疗斑秃52例[J].皮肤病与性病,2004,26(1):20-20)
[37]马小军,陈焱.中药内服外洗治疗斑秃[J].实用中医内科杂志,2007,21(9):91
[38]彭东,王春奇,冯畅洁.内服外薰法治疗斑秃1例[J].吉林医药学院学报,2006,27(2):98
[39]吴文芝.养血生发搽剂治疗斑秃86例[J].江苏中医药,2005,26(12):8
[40]张生彦.中药浸测剂治疗斑秃36例临床体会[J].中国医学理论与实践,2007,17(07):734
[41]王根会,冯兰珍,刘焕强,赵云夕.自拟生发液外用治疗斑秃100例疗效观察[J].河北中医,2007,29(11):989
[42]付相钰.中药外搽治疗斑秃56例[J].中医外治杂志,2007,16(6):54
[43]岳艳.水针结合体针治疗斑秃35例[J].中医药临床杂志,2006,18(2):145
[44]王萍.隔姜灸加俸针治疗斑秃33例[J].中国中医药科技,2006,13(2):123
[45]韩春玉,于德茹,张淑花.56例斑秃梅花针扣刺配合氦氖激光照射治疗[J].中 国现代药物应用,2007,1(4):13
[46]孟子邹.皮肤针治疗斑秃39例[J].浙江中医杂志,2008,43(3):166
[47]熊修安,严宝珠.刺激神经疗法配合生发液治疗斑秃的临床疗效观察[J].针灸临床杂志,2007,23(2):11
[48]朱启玉,吴芳华.梅花针配合体针治疗斑秃疗效观察[J].上海针灸杂志,2008,27(1):27-28
[49]杨青,朱文红.梅花针、雀啄灸合穴位注射治疗斑秃33例[J].江苏中医药,2008,40(2):51
[50]杨瑞海,牟丽萍,王松芬.神应养真丹对斑秃患者细胞免疫功能的影响[J].辽宁中医杂志.2007,34(4):392-393
[51]卢浩锵,黄霖,刘华,吴淑娴.生发乌发口服液治疗斑秃临床研究[J].中国中医急症,2004,13(4):215-216
[52]马平勃.生发灵酊治疗斑秃280例[J].医药导报,2003,22(6):385-386
[53]朱培成,禤国维,陈达灿,范瑞强.黄芪多糖对斑秃患者PBMC中Th1/Th2型细胞因子、转录因子T-bet mRNA表达的调节作用[J].广东医学2007,28(10):1685-1687
[54]朱培成,禤国维,陈达灿,范瑞强.原花青素对斑秃患者外周血单核细胞中IFN-γ、IL-12及转录因子T-bet基因表达的调节作用[J].中国中西医结合杂志,2008年,28(10):900-902
[55]徐倩,沈亮亮.丹参在斑秃的临床应用及微循环观察[J].上海医学,2006,29(4):236-238
[56]朱培成,禤国维,陈达灿,范瑞强.肝肾不足型斑秃患者PBMC中Th1/Th2型细胞因子转录因子T-bet mRNA表达状况[J].中华中医药学刊2007,25(5):937-939
[57]吴元胜,黄咏菁.禤国维教授治疗重型斑秃经验介绍[J].新中医,2003,35(2):10-11
[58]邹世光,张琴.中药治疗顽固性斑秃55例[J].现代中医,1997,(2):88
[59]孟作仁,肖文彤,鲍先琬.中药黄芪治疗顽固性斑秃87例[J].中国皮肤性病学杂志,1994,(3):170
[60]李佳伶,霍平,张素华.蝮蛇抗栓酶治疗顽固性斑秃64例[J].综合临床医学,1996,(2):78
[61]马计美,赵家怡.皮肤针配合中药治疗难治性斑秃32例疗效观察[J].工企医刊,2001,14(5):57
[62]戴晓云,陈全宜.生发丸加梅花针治疗顽固性斑秃20例[J].国医论坛,2000,15(2):37
[63]张景政,刘荣卿,叶庆佾,等.长压定、强的松治疗重型斑秃对比观察[J].临床皮肤科杂志,1990,(6):299
[64]李广志.系统应用皮质类固醇治疗重型斑秃[j].国外医学·皮肤性病学分册,1 999,25(4):242
[65]周小勇.甲泼尼龙冲击疗法治疗严重斑秃:对45例患者的开放性前瞻性研究[J].国外医学·皮肤性病学分册,1999,25(4):242
[66]谭凤明,侯显曾,张滨岳.两种方法使用皮质激素治疗重型斑秃的对比观察[J].广州医学院学报,1997,(4):48
[67]李蔚林,李智勇.中西医结合治疗重型斑秃32例疗效报告[J].临床皮肤科杂志,1994,(1):49
[68]刘军,陈剑.UV-N光照射治疗重型斑秃疗效观察[J].青海医药杂志,2003,33(10):43
[69]黄早发,王冰.中西药结合治疗重型斑秃94例疗效观察[J].中国社区医师,2006,(10):56-57
[70]胡东流,陈达灿,榻国维.综合疗法治疗重型斑秃33例[J].新中医,2001,(10):52
[71]胡东流,陈达灿,范瑞强,禤国维中西医结合疗法治疗全秃普秃的临床疗效观察[J].广州中医药大学学报,2003,20(4):274-275
[72]黄家珍.醋酸确炎松局封及口服中药治疗重型斑秃43例报告[J].临床皮肤科杂志,1996,(3):186
[73]陈达灿,禤国维,主编.专科专病中医治疗全书·皮肤病分册[M].北京:人民卫生出版社,2000:162
[74]Gilhar A,Shalaginov R,Assy B,et al.Alopecia area mediated autoimmune disease:lesinal humanT-1 alopecia areata to human skin grafts on SCID mice[J].Symp Proc,1999,4(3):207-210.
[75]陈军生,何洁冰,魏旷荣,等.斑秃患者血T细胞变化及其凋亡信号控制[J].中华美容医学杂志,2002,8(1):23-26.
[76]Tsuboi,Tanei R,FujimuraT,etal.Characterization of Infiltrating T cel ls in human scalp explants from alopecia areta to SCID nude mice:possi ble role of the disappearance of CD8~+ T lyphocytes in the process of hair regrowth[J].J Dermatol,1999,26(12):797-802
[77]McElwee KJ,Hoffmann R.Alopecia areta-animal models[J].Clinical and Experimental Dermatol.2002,27:410-417.
[78]黄卫宁,侯显曾,卢浩锵,等.T淋巴细胞亚群与斑秃发病关系的研究[J].岭南皮肤性病科杂志,2007,14(4):209
[79]陈小敏,杨秀丽,史维平,等.斑秃患者外周血CD4~+CD25~+Foxp 3调节T细胞及T 淋巴细胞亚群的测定[J].中华皮肤科杂志,2008,41(1):29-32
[80]陈丽芳,史维平,刘金华,等.斑秃患者皮损处T淋巴细胞表型的研究及Fas的表达[J].山西医药杂志,2005,34(1):9
[81]Gilhar A,Landau M,Assy B,et al.Transfer of alopecia areata in human scalp graft/Prkdcscid(SCID)mouse system is characterized by a Thl response[J].Clin Immunol,2003,106(3):181-181.
[82]赵磊,范卫新,汤爱民.毛囊赦免与免疫[J].国外医学皮肤性病学分册,2003,28(2):99-102
[83]代秀菊,涂平,秦俭,等.几种细胞因子与斑秃发病关系的初步研究[J].中华皮肤科杂志,2002,35(1):53
[84]罗敏,黄进华,廖朝晖,等.斑秃患者血清γ干扰素和白介素10水平的研究[J].岭南皮肤性病学杂志,2004,11(1):6-8
[85]蔡晓伟,李惠.IFN-γ、IL-10与斑秃关系的初步研究[J].中国现代实用医学杂,2007,6(4):11
[86]梁刘萍,曾抗,李莉。斑秃患者血清白介素18和肿瘤坏死因子的检测[J].中国麻风皮肤病杂志,2005,21(10):788
[87]刘国英,姚航平.斑秃患者血清转化因子β 1水平及脱发面积关系的研究[J].中华 皮肤科杂志,2000,33(1):46
[88]许冰,王勇刚,吴灵娇.斑秃患者血清中几种细胞因子的检测[J].中华皮肤科杂志,2006,39(4):219-220
[89]曹海育,李建英,刘英权.斑秃患者肿瘤坏死因子-α和白介素-2水平与人巨细胞病毒感染相关性分析[J].河北医药,2007.29(11):1199
[90]Bodemer C,Peuchmaur M,Fraitaig S,et al.Role of cytotoxic T cell in chronic alopecia areata[J].J Invest Dermatol 2000,114(1):112--116
[91]张谊之,张敏,王林,等.斑秃皮损中Fas及Fas配体的免疫组化研究[J].临床皮肤科杂志,2002,31(1):27-28.
[92]高顺强,李美洲,张学新.斑秃皮损区毛囊角质形成细胞超微结构的初步观察[J].河北医科大学学报,2002,23(6):343-344
[93]刘晓红,赵书平,王君松.斑秃患者皮损巨细胞病毒的检测[J].中华皮肤科杂志,2000,33(40):283-84
[94]鞠玉蕊,巫毅,袁久彤,等.斑秃与巨细胞病毒感染的关系[J].中华皮肤科杂志,2004,37(3):169
[95]Offidani A,Amerio P.Bernardini ML,et al.Role of cytomegalovirus replicatoin in alopecia areata pathogelaesis[J].J Cutan Med,2000,4(2):63-65
[96]张景政,刘荣卿,叶庆佾.长压定、强的松治疗重型斑秃对比观察[J].临床皮 肤科杂志,1990,6:299-301
[97]陈达灿,禤国维主编.皮肤性病科专病中医临床诊治[M].第一版.北京:人民卫生出版社,2000:159
[98]靳培英主编.皮肤病药物治疗学[M].第一版.北京:人民卫生出版社,2004:281
[99]李广志.系统应用皮质类固醇治疗重型斑秃[J].国外医学·皮肤性病学分册,1999,25(4):242
[100]周小勇.甲泼尼龙冲击疗法治疗严重斑秃:对45例患者的开放性前瞻性研究[J].国外医学·皮肤性病学分册,1999,25(4):242
[101]谭风明,侯显曾,张滨岳.两种方法使用皮质激素治疗重型斑秃的对比观察[J].广州医学院学报,1997,(4):48
[102]Jusko WJ.Pharmacokinetics and receptor-mediated pharmacodynamis of corticosteroids.Toxicology 1995:102:189-196.
[103]万力生,范红霞.中医治疗脱发的方药统计与述评[J].浙江中西医结合杂志.2000,10(9):564
[104]禤国维,范瑞强,陈达灿主编.中医皮肤病临证精粹[M].第1版.广州:广东人民出版社,2001:141
[105]凌昌全,李敏,谭金兴,等.中药对糖皮质激素受体保护作用的实验研究[J].中国中西医结合杂志,1999,19(5):302-303
[106]凌昌全,陈喆,俞超芹,等.52例阴虚阳虚患者外周血混合白细胞糖皮质激素受体的实验观察[J].中医杂志,1998,39(10):619-620.
[107]杨宏杰,郑敏.阳虚患者糖皮质激素受体改变及金匮肾气丸作用的研究[J].第二军医大学学报,2001,22(11):1084
[108]刘福春,翟美芙.老年及老年虚证病人周围血白细胞糖皮质激素受体的研究[J].中医杂志,1989,30(7):40-42
[109]张家庆,刘志民.阳虚患者单个核及多形核白细胞糖皮质激素受体改变[J].中西医结合杂志,1990,10(4):215-216
[110]姚连初.肾气丸对原发肾病综合征患者外周血糖皮质激素受体水平的影响[J].中成药2000;22(10):704-705
[111]马以泉.六昧地黄丸对肾病综合征患儿外周血糖皮质激素受体水平的影响[J].浙江中医学院学报,2000,2(3):49
[112]Andreae J,Tripmacher R,Weltrich R,et al.Effect of glucocorticoidtherapy on glucocorticoid receptors in children with auto immune diseses[J].Pediatr Res,2001,49:130-135.
[113]Oakley RH,Cidlowski JA.Homologous down regulation of the glucocorticoid receptor:the molecular machinery[J].Crit Rev Eukaryot Gene Expr,1993, receptor:the molecular machinery[J].Crit Rev Eukaryot Gene Expr,1993,3:63-88.
[114]Sanden S,Tripmacher R,Weltrich R,etal.Glucocorticoid dose dependent downregnlation of glucocorticoid receptors in patients with rheumatic diseasestj].J Rheumatol,2000,27:1265-1270
[2]赵艳霞,陈学荣.陈学荣教授中医治疗脱发的临床经验[J]中国中西医结合皮肤性病学杂志,2006,5(2):103
[3]马纯清.补阳还五汤加味应用举隅[J].长春中医药大学学报.2006,22(4):24-25
[4]王丽华.益肾养血汤治疗斑秃40例[J].河北中医,2006,28(3):182-182
[5]王卫.六味地黄汤治疗斑秃的体会[J].中华现代中西医杂志,2005,3(7):637-637
[6]陈忠春.生发汤治疗斑秃260例疗效观察[J].中国中西医结合皮肤性病学杂志,2004,3(3):165-166.
[7]程晓春,龚一云,岳代荣.补阳还五汤加味治疗斑秃80例[J].四川中医,2004,22(2):72-73
[8]张凌.自拟补肾活血驱风汤治疗斑秃32例[J].福建中医药,2006,37(1):34.
[9]卢纬花.逍遥散加减治疗斑秃48例[J].实用中医杂志,2007,23(7):436
[10]赵义恩 赵泽恩.桑楮生发汤治疗斑秃36例[J].四川中医,2004,22(1):82-8
[11]袁翠英.中医药治疗斑秃102例[J].中华皮肤科杂志,2004,37(2):113-113
[12]潘权.自拟苦参汤治疗斑秃21例疗效观察[J].哈尔滨医药,2003,23(5):41-42
[13]张贵菊,龙雪.首乌神应丹治疗斑秃76例观察[J].实用中医药杂志,2006,22(8):470.
[14]朱培成.松针滋肾生发汤治疗斑秃的疗效[J].广东医学,2007年,28(12):2030-2031
[15]李云华,马俊彦.疏肝活血法治疗斑秃的体会[J].云南中医学院学报,2004,27(4):44-45
[16]杨红.柴胡疏肝散加减治疗斑秃100例[J].中国中西医结合皮肤性病学杂志,2005,4(1):43.
[17]胡爱玲.内外同治斑秃18例疗效观察[J].湖南中医杂志,2008,24(2):42-43
[18]刘爱民 吴晓霞 禤国维.血瘀与活血化瘀在斑秃发病及治疗中的作用[J].浙江中医杂志,2004,39(1):10-11
[19]马艳春.从痰热论治斑秃38例[J].黑龙江中医药杂志,2007,24(6):44
[20]李秀潘.斑秃证治与阴阳转折疗法[J].辽宁中医杂志,2006,33(10):1349.
[21]袁新顺.中医综合疗法治斑秃34例[J].中国民间疗法,2004,12(7):38-39
[22]谢雄飞.梅花针配合中药酊外搽治疗斑秃100例[J].中国中医药杂志,2005,3(11):1026-1026
[23]温瑞书,刘忙柱.化瘀生发汤配合皮肤针治疗斑秃56例[J].四川中医,2003, 21(7):85-85
[24]刘秀玲.穴位注射合辨证分型治疗斑秃130例[J].福建中医学院学报,2003,13(3):11-11
[25]吴晓永.针药并用治疗斑秃96例临床观察[J].中华综合医学杂志(河北),2003,5(5):62-63
[26]戴蜀平.针药并用治疗斑秃临床观察.辽宁中医杂志,2003,30(9):749-749)
[27]王敏华,于雪梅,邓家侵,等.中医综合疗法治疗斑秃的疗效观察[J].2007,25.(9):100
[28]张恒耀,李鸣九,黄青林,等.综合疗法治疗斑秃68例疗效观察[J].新巾医,2006,38(4):66
[29]于洪芝.四联疗法治疗斑秃疗效观察[J].岭南皮肤性病科杂志,2008,15(4):216-217
[30]赖晓梅,曹艳霞,刘健.电针加药物注射治疗斑秃62例疗效观察[J].四川中医,2004,22(2):77--78.
[31]陈金兰.针刺配合中药治疗斑秃80例[J].辽宁中医杂志,2007,34(12):1791
[32]陈训军,丹红酊治疗斑秃38例[J].医药导报,2003,22(1):50
[33]赵昌兰.皮肤病外治验案举隅[J].中华现代皮肤科学杂志,2005,2(1):70-70
[34]梁绿茵 蔡敬宙 何颖妉.梅花针加万丝林喷雾剂治疗瘀血阻络型斑秃临床研究[J].辽宁中医杂志,2004,31(7):598-599
[35]何良新.斑蝥酊治疗斑秃64例[J].中国现代中西医结合,2004,1(4):330-33
[36]曹晓丽,韦宗杰.梅花针加自拟中药酊剂治疗斑秃52例[J].皮肤病与性病,2004,26(1):20-20)
[37]马小军,陈焱.中药内服外洗治疗斑秃[J].实用中医内科杂志,2007,21(9):91
[38]彭东,王春奇,冯畅洁.内服外薰法治疗斑秃1例[J].吉林医药学院学报,2006,27(2):98
[39]吴文芝.养血生发搽剂治疗斑秃86例[J].江苏中医药,2005,26(12):8
[40]张生彦.中药浸测剂治疗斑秃36例临床体会[J].中国医学理论与实践,2007,17(07):734
[41]王根会,冯兰珍,刘焕强,赵云夕.自拟生发液外用治疗斑秃100例疗效观察[J].河北中医,2007,29(11):989
[42]付相钰.中药外搽治疗斑秃56例[J].中医外治杂志,2007,16(6):54
[43]岳艳.水针结合体针治疗斑秃35例[J].中医药临床杂志,2006,18(2):145
[44]王萍.隔姜灸加俸针治疗斑秃33例[J].中国中医药科技,2006,13(2):123
[45]韩春玉,于德茹,张淑花.56例斑秃梅花针扣刺配合氦氖激光照射治疗[J].中 国现代药物应用,2007,1(4):13
[46]孟子邹.皮肤针治疗斑秃39例[J].浙江中医杂志,2008,43(3):166
[47]熊修安,严宝珠.刺激神经疗法配合生发液治疗斑秃的临床疗效观察[J].针灸临床杂志,2007,23(2):11
[48]朱启玉,吴芳华.梅花针配合体针治疗斑秃疗效观察[J].上海针灸杂志,2008,27(1):27-28
[49]杨青,朱文红.梅花针、雀啄灸合穴位注射治疗斑秃33例[J].江苏中医药,2008,40(2):51
[50]杨瑞海,牟丽萍,王松芬.神应养真丹对斑秃患者细胞免疫功能的影响[J].辽宁中医杂志.2007,34(4):392-393
[51]卢浩锵,黄霖,刘华,吴淑娴.生发乌发口服液治疗斑秃临床研究[J].中国中医急症,2004,13(4):215-216
[52]马平勃.生发灵酊治疗斑秃280例[J].医药导报,2003,22(6):385-386
[53]朱培成,禤国维,陈达灿,范瑞强.黄芪多糖对斑秃患者PBMC中Th1/Th2型细胞因子、转录因子T-bet mRNA表达的调节作用[J].广东医学2007,28(10):1685-1687
[54]朱培成,禤国维,陈达灿,范瑞强.原花青素对斑秃患者外周血单核细胞中IFN-γ、IL-12及转录因子T-bet基因表达的调节作用[J].中国中西医结合杂志,2008年,28(10):900-902
[55]徐倩,沈亮亮.丹参在斑秃的临床应用及微循环观察[J].上海医学,2006,29(4):236-238
[56]朱培成,禤国维,陈达灿,范瑞强.肝肾不足型斑秃患者PBMC中Th1/Th2型细胞因子转录因子T-bet mRNA表达状况[J].中华中医药学刊2007,25(5):937-939
[57]吴元胜,黄咏菁.禤国维教授治疗重型斑秃经验介绍[J].新中医,2003,35(2):10-11
[58]邹世光,张琴.中药治疗顽固性斑秃55例[J].现代中医,1997,(2):88
[59]孟作仁,肖文彤,鲍先琬.中药黄芪治疗顽固性斑秃87例[J].中国皮肤性病学杂志,1994,(3):170
[60]李佳伶,霍平,张素华.蝮蛇抗栓酶治疗顽固性斑秃64例[J].综合临床医学,1996,(2):78
[61]马计美,赵家怡.皮肤针配合中药治疗难治性斑秃32例疗效观察[J].工企医刊,2001,14(5):57
[62]戴晓云,陈全宜.生发丸加梅花针治疗顽固性斑秃20例[J].国医论坛,2000,15(2):37
[63]张景政,刘荣卿,叶庆佾,等.长压定、强的松治疗重型斑秃对比观察[J].临床皮肤科杂志,1990,(6):299
[64]李广志.系统应用皮质类固醇治疗重型斑秃[j].国外医学·皮肤性病学分册,1 999,25(4):242
[65]周小勇.甲泼尼龙冲击疗法治疗严重斑秃:对45例患者的开放性前瞻性研究[J].国外医学·皮肤性病学分册,1999,25(4):242
[66]谭凤明,侯显曾,张滨岳.两种方法使用皮质激素治疗重型斑秃的对比观察[J].广州医学院学报,1997,(4):48
[67]李蔚林,李智勇.中西医结合治疗重型斑秃32例疗效报告[J].临床皮肤科杂志,1994,(1):49
[68]刘军,陈剑.UV-N光照射治疗重型斑秃疗效观察[J].青海医药杂志,2003,33(10):43
[69]黄早发,王冰.中西药结合治疗重型斑秃94例疗效观察[J].中国社区医师,2006,(10):56-57
[70]胡东流,陈达灿,榻国维.综合疗法治疗重型斑秃33例[J].新中医,2001,(10):52
[71]胡东流,陈达灿,范瑞强,禤国维中西医结合疗法治疗全秃普秃的临床疗效观察[J].广州中医药大学学报,2003,20(4):274-275
[72]黄家珍.醋酸确炎松局封及口服中药治疗重型斑秃43例报告[J].临床皮肤科杂志,1996,(3):186
[73]陈达灿,禤国维,主编.专科专病中医治疗全书·皮肤病分册[M].北京:人民卫生出版社,2000:162
[74]Gilhar A,Shalaginov R,Assy B,et al.Alopecia area mediated autoimmune disease:lesinal humanT-1 alopecia areata to human skin grafts on SCID mice[J].Symp Proc,1999,4(3):207-210.
[75]陈军生,何洁冰,魏旷荣,等.斑秃患者血T细胞变化及其凋亡信号控制[J].中华美容医学杂志,2002,8(1):23-26.
[76]Tsuboi,Tanei R,FujimuraT,etal.Characterization of Infiltrating T cel ls in human scalp explants from alopecia areta to SCID nude mice:possi ble role of the disappearance of CD8~+ T lyphocytes in the process of hair regrowth[J].J Dermatol,1999,26(12):797-802
[77]McElwee KJ,Hoffmann R.Alopecia areta-animal models[J].Clinical and Experimental Dermatol.2002,27:410-417.
[78]黄卫宁,侯显曾,卢浩锵,等.T淋巴细胞亚群与斑秃发病关系的研究[J].岭南皮肤性病科杂志,2007,14(4):209
[79]陈小敏,杨秀丽,史维平,等.斑秃患者外周血CD4~+CD25~+Foxp 3调节T细胞及T 淋巴细胞亚群的测定[J].中华皮肤科杂志,2008,41(1):29-32
[80]陈丽芳,史维平,刘金华,等.斑秃患者皮损处T淋巴细胞表型的研究及Fas的表达[J].山西医药杂志,2005,34(1):9
[81]Gilhar A,Landau M,Assy B,et al.Transfer of alopecia areata in human scalp graft/Prkdcscid(SCID)mouse system is characterized by a Thl response[J].Clin Immunol,2003,106(3):181-181.
[82]赵磊,范卫新,汤爱民.毛囊赦免与免疫[J].国外医学皮肤性病学分册,2003,28(2):99-102
[83]代秀菊,涂平,秦俭,等.几种细胞因子与斑秃发病关系的初步研究[J].中华皮肤科杂志,2002,35(1):53
[84]罗敏,黄进华,廖朝晖,等.斑秃患者血清γ干扰素和白介素10水平的研究[J].岭南皮肤性病学杂志,2004,11(1):6-8
[85]蔡晓伟,李惠.IFN-γ、IL-10与斑秃关系的初步研究[J].中国现代实用医学杂,2007,6(4):11
[86]梁刘萍,曾抗,李莉。斑秃患者血清白介素18和肿瘤坏死因子的检测[J].中国麻风皮肤病杂志,2005,21(10):788
[87]刘国英,姚航平.斑秃患者血清转化因子β 1水平及脱发面积关系的研究[J].中华 皮肤科杂志,2000,33(1):46
[88]许冰,王勇刚,吴灵娇.斑秃患者血清中几种细胞因子的检测[J].中华皮肤科杂志,2006,39(4):219-220
[89]曹海育,李建英,刘英权.斑秃患者肿瘤坏死因子-α和白介素-2水平与人巨细胞病毒感染相关性分析[J].河北医药,2007.29(11):1199
[90]Bodemer C,Peuchmaur M,Fraitaig S,et al.Role of cytotoxic T cell in chronic alopecia areata[J].J Invest Dermatol 2000,114(1):112--116
[91]张谊之,张敏,王林,等.斑秃皮损中Fas及Fas配体的免疫组化研究[J].临床皮肤科杂志,2002,31(1):27-28.
[92]高顺强,李美洲,张学新.斑秃皮损区毛囊角质形成细胞超微结构的初步观察[J].河北医科大学学报,2002,23(6):343-344
[93]刘晓红,赵书平,王君松.斑秃患者皮损巨细胞病毒的检测[J].中华皮肤科杂志,2000,33(40):283-84
[94]鞠玉蕊,巫毅,袁久彤,等.斑秃与巨细胞病毒感染的关系[J].中华皮肤科杂志,2004,37(3):169
[95]Offidani A,Amerio P.Bernardini ML,et al.Role of cytomegalovirus replicatoin in alopecia areata pathogelaesis[J].J Cutan Med,2000,4(2):63-65
[96]张景政,刘荣卿,叶庆佾.长压定、强的松治疗重型斑秃对比观察[J].临床皮 肤科杂志,1990,6:299-301
[97]陈达灿,禤国维主编.皮肤性病科专病中医临床诊治[M].第一版.北京:人民卫生出版社,2000:159
[98]靳培英主编.皮肤病药物治疗学[M].第一版.北京:人民卫生出版社,2004:281
[99]李广志.系统应用皮质类固醇治疗重型斑秃[J].国外医学·皮肤性病学分册,1999,25(4):242
[100]周小勇.甲泼尼龙冲击疗法治疗严重斑秃:对45例患者的开放性前瞻性研究[J].国外医学·皮肤性病学分册,1999,25(4):242
[101]谭风明,侯显曾,张滨岳.两种方法使用皮质激素治疗重型斑秃的对比观察[J].广州医学院学报,1997,(4):48
[102]Jusko WJ.Pharmacokinetics and receptor-mediated pharmacodynamis of corticosteroids.Toxicology 1995:102:189-196.
[103]万力生,范红霞.中医治疗脱发的方药统计与述评[J].浙江中西医结合杂志.2000,10(9):564
[104]禤国维,范瑞强,陈达灿主编.中医皮肤病临证精粹[M].第1版.广州:广东人民出版社,2001:141
[105]凌昌全,李敏,谭金兴,等.中药对糖皮质激素受体保护作用的实验研究[J].中国中西医结合杂志,1999,19(5):302-303
[106]凌昌全,陈喆,俞超芹,等.52例阴虚阳虚患者外周血混合白细胞糖皮质激素受体的实验观察[J].中医杂志,1998,39(10):619-620.
[107]杨宏杰,郑敏.阳虚患者糖皮质激素受体改变及金匮肾气丸作用的研究[J].第二军医大学学报,2001,22(11):1084
[108]刘福春,翟美芙.老年及老年虚证病人周围血白细胞糖皮质激素受体的研究[J].中医杂志,1989,30(7):40-42
[109]张家庆,刘志民.阳虚患者单个核及多形核白细胞糖皮质激素受体改变[J].中西医结合杂志,1990,10(4):215-216
[110]姚连初.肾气丸对原发肾病综合征患者外周血糖皮质激素受体水平的影响[J].中成药2000;22(10):704-705
[111]马以泉.六昧地黄丸对肾病综合征患儿外周血糖皮质激素受体水平的影响[J].浙江中医学院学报,2000,2(3):49
[112]Andreae J,Tripmacher R,Weltrich R,et al.Effect of glucocorticoidtherapy on glucocorticoid receptors in children with auto immune diseses[J].Pediatr Res,2001,49:130-135.
[113]Oakley RH,Cidlowski JA.Homologous down regulation of the glucocorticoid receptor:the molecular machinery[J].Crit Rev Eukaryot Gene Expr,1993, receptor:the molecular machinery[J].Crit Rev Eukaryot Gene Expr,1993,3:63-88.
[114]Sanden S,Tripmacher R,Weltrich R,etal.Glucocorticoid dose dependent downregnlation of glucocorticoid receptors in patients with rheumatic diseasestj].J Rheumatol,2000,27:1265-1270